Technology for sleep disorders.
Respironics plans to market a number of PAT-based products for sleep medicine, including the PAT Watch 100[TM], a lightweight, wrist-worn device for home use, and the PAT Sleep 200, a bedside unit for in-clinic use. In addition, the companies intend to develop products integrating the PAT technology into sleep lab diagnostic equipment. The commercial introduction of the new products in the United States is planned for next year, subject to obtaining the required regulatory approvals. The final agreement is subject to customary conditions, including required approvals and consents.
|Printer friendly Cite/link Email Feedback|
|Publication:||Ear, Nose and Throat Journal|
|Date:||Oct 1, 2000|
|Previous Article:||Mucosal atomizer.|
|Next Article:||Compact otoscope.|